Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Relief Therapeutics Hldg Ag (RLFTY)

Relief Therapeutics Hldg Ag (RLFTY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4000 +74.28%
on 12/15/25
3.8800 -37.12%
on 12/11/25
-1.3601 (-35.79%)
since 12/09/25
3-Month
1.4000 +74.28%
on 12/15/25
4.0500 -39.76%
on 11/03/25
-2.4601 (-50.21%)
since 10/08/25
52-Week
1.4000 +74.28%
on 12/15/25
4.9000 -50.21%
on 10/08/25
-2.0601 (-45.78%)
since 01/08/25

Most Recent Stories

More News
Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update

GENEVA, SWITZERLAND / ACCESS Newswire / April 10, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief), a biopharmaceutical company committed to delivering innovative treatment...

RLFTY : 2.4399 (+6.55%)
RLFTF : 1.8800 (-2.59%)
Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion

GENEVA, SWITZERLAND / ACCESS Newswire / March 6, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative...

RLFTY : 2.4399 (+6.55%)
RLFTF : 1.8800 (-2.59%)
Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011

Patent Secures Protection for RLF-TD011 in Epidermolysis Bullosa Wound Treatment

RLFTY : 2.4399 (+6.55%)
RLFTF : 1.8800 (-2.59%)
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US

Sale of GOLIKE® Rights Outside the U.S. to NutrisensRelief to Focus on R&D of Pipeline Assets and Licensing for Commercialized Products

RLFTY : 2.4399 (+6.55%)
RLFTF : 1.8800 (-2.59%)
Relief Therapeutics Provides Update on Potential Transaction with Renexxion

GENEVA, SWITZERLAND / ACCESSWIRE / December 27, 2024 / RELIEF THERAPEUTICS Holding SA(SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative...

RLFTY : 2.4399 (+6.55%)
RLFTF : 1.8800 (-2.59%)
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial

Clinical Trial Demonstrates Superior Metabolic Control During Prolonged Fasting in PKU Patients

RLFTY : 2.4399 (+6.55%)
RLFTF : 1.8800 (-2.59%)
Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations

Company to Maintain SIX Swiss Exchange Listing, U.S. ADR Program, and U.S. OTCQB Quotation

RLFTY : 2.4399 (+6.55%)
RLFTF : 1.8800 (-2.59%)
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements

/PRNewswire/ -- RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), and NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx...

RLFTY : 2.4399 (+6.55%)
NRXP : 2.22 (unch)
RELIEF THERAPEUTICS HOLDING SA AND NRX PHARMACEUTICALS, INC. ANNOUNCE TENTATIVE SETTLEMENT OF PENDING LITIGATION

/PRNewswire/ -- RELIEF THERAPEUTICS Holding SA (SIX: RLF) (OTCQB: RLFTF) (OTCQB: RLFTY) ("Relief"), and NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) ("NRx"), today...

RLFTY : 2.4399 (+6.55%)
NRXP : 2.22 (unch)
RLFTF : 1.8800 (-2.59%)
Relief Therapeutics Announces Effectiveness of Registration Statement on Form 20-F

GENEVA, SWITZERLAND / ACCESSWIRE / July 21, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief ") announced today that the U.S. Securities and Exchange Commission (" SEC ") has...

RLFTY : 2.4399 (+6.55%)
RLFTF : 1.8800 (-2.59%)

Key Turning Points

3rd Resistance Point 2.8664
2nd Resistance Point 2.6532
1st Resistance Point 2.5465
Last Price 2.4399
1st Support Level 2.2266
2nd Support Level 2.0134
3rd Support Level 1.9067

See More

52-Week High 4.9000
Fibonacci 61.8% 3.5630
Fibonacci 50% 3.1500
Fibonacci 38.2% 2.7370
Last Price 2.4399
52-Week Low 1.4000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar